Research Topics
Species | Andrew J FarmerSummaryAffiliation: University of Oxford Country: UK Publications
| Collaborators
|
Detail Information
Publications
The impact of screening for Type 2 diabetes in siblings of patients with established diabetesA J Farmer
Department of Primary Health Care, University of Oxford
Diabet Med 20:996-1004. 2003..Targeted screening for Type 2 diabetes has been proposed as a method of identifying people with, or at risk of, the disease in order to implement preventive care...
Impact of self monitoring of blood glucose in the management of patients with non-insulin treated diabetes: open parallel group randomised trialAndrew Farmer
Department of Primary Health Care, University of Oxford, Oxford OX2 7LF
BMJ 335:132. 2007..To determine whether self monitoring, alone or with instruction in incorporating the results into self care, is more effective than usual care in improving glycaemic control in non-insulin treated patients with type 2 diabetes...
Blood glucose self-monitoring in type 2 diabetes: a randomised controlled trialA J Farmer
Department of Primary Health Care, NIHR School of Primary Care Research, University of Oxford, UK
Health Technol Assess 13:iii-iv, ix-xi, 1-50. 2009....- Challenges of maintaining research protocol fidelity in a clinical care setting: a qualitative study of the experiences and views of patients and staff participating in a randomized controlled trialJulia Lawton
Centre for Population Health Sciences, University of Edinburgh, Medical School, Teviot Place, Edinburgh, EH8 9AG, UK
Trials 12:108. 2011..5%) among patients who participated in the Treating to Target in Type 2 Diabetes Trial (4-T). The objective was to inform interpretation of trial outcomes and provide recommendations for future trial delivery... - The Diabetes Manual trial protocol - a cluster randomized controlled trial of a self-management intervention for type 2 diabetes [ISRCTN06315411]Jackie Sturt
Centre for Primary Health Care Studies, Warwick Medical School, University of Warwick, Coventry, CV4 7AL, UK
BMC Fam Pract 7:45. 2006..It is a one to one intervention meeting United Kingdom requirements for structured diabetes-education and is delivered within routine primary care... - Protocol for SAMS (Support and Advice for Medication Study): a randomised controlled trial of an intervention to support patients with type 2 diabetes with adherence to medicationAndrew J Farmer
Department of Primary Health Care, University of Oxford, Oxford, OX3 7LF, UK
BMC Fam Pract 9:20. 2008..We have developed a theory-based intervention which we will evaluate in a well characterised population to test efficacy and guide future intervention development and trial design... - Individual patient data meta-analysis of trials of self-monitoring of blood glucose in non-insulin treated type 2 diabetes: protocol for a systematic reviewA J Farmer
Department of Primary Health Care, NIHR School of Primary Care Research, University of Oxford, Oxford, UK
Prim Care Diabetes 3:117-21. 2009..We will systematically examine these factors within the trials of SMBG to enable further investigation of the data through an individual patient data analysis (IPD)... - Frequency of self-monitoring of blood glucose in patients with type 2 diabetes: association with hypoglycaemic eventsAndrew Farmer
Department of Primary Health Care, University of Oxford, Oxford, UK
Curr Med Res Opin 24:3097-104. 2008..In addition, the study aims to investigate the association of SMBG and self-reported episodes of low blood glucose... - Metabolic syndrome and mortalityAndrew Farmer
Department of Primary Health Care, University of Oxford, Oxford OX3 7LF
BMJ 332:882. 2006 - Measuring beliefs about taking hypoglycaemic medication among people with Type 2 diabetesA Farmer
Department of Primary Health Care, University of Oxford, Oxford, UK
Diabet Med 23:265-70. 2006..We set out to establish the range of these beliefs, and measure the frequency of commonly held beliefs and their correlation with intention to take medication and self-reported medication adherence... - A real-time, mobile phone-based telemedicine system to support young adults with type 1 diabetesAndrew Farmer
Department of Primary Health Care, University of Oxford, UK
Inform Prim Care 13:171-7. 2005.... - A randomized controlled trial of the effect of real-time telemedicine support on glycemic control in young adults with type 1 diabetes (ISRCTN 46889446)Andrew J Farmer
Division of Public Health and Primary Health Care, University of Oxford, Oxford, UK
Diabetes Care 28:2697-702. 2005..To determine whether a system of telemedicine support can improve glycemic control in type 1 diabetes... - A systematic review of telemedicine interventions to support blood glucose self-monitoring in diabetesA Farmer
Division of Public Health and Primary Health Care, University of Oxford, Oxford, UK
Diabet Med 22:1372-8. 2005..To evaluate evidence for feasibility, acceptability and cost-effectiveness of diabetes telemedicine applications... - In a randomized trial, outcomes were not affected by intensive follow-up over 1 yearAndrew J Farmer
Department of Primary Health Care, University of Oxford, Old Road Campus, Oxford OX3 7LF, UK
J Clin Epidemiol 58:991-6. 2005..This study tested the impact on response and psychological measures of different follow-up schedules for participants in a study screening for type 2 diabetes risk... - The DiGEM trial protocol--a randomised controlled trial to determine the effect on glycaemic control of different strategies of blood glucose self-monitoring in people with type 2 diabetes [ISRCTN47464659]Andrew Farmer
Department of Primary Health Care, University of Oxford, Old Road Campus, Oxford, OX3 7LF, UK
BMC Fam Pract 6:25. 2005..Training in monitoring may be most effective in improving glycaemic control and well being when results are linked to behavioural change... - Knowledge of risk of developing diabetes mellitus among siblings of Type 2 diabetic patientsA J Farmer
Department of Public Health, University of Oxford, UK
Diabet Med 16:233-7. 1999..We set out to investigate the extent to which siblings of diabetic subjects perceived themselves likely to develop Type 2 diabetes mellitus (DM) when offered screening tests... - Three-year efficacy of complex insulin regimens in type 2 diabetesRury R Holman
Diabetes Trials Unit, Oxford Centre for Diabetes, Endocrinology and Metabolism, University of Oxford, Oxford, United Kingdom
N Engl J Med 361:1736-47. 2009..Evidence supporting the addition of specific insulin regimens to oral therapy in patients with type 2 diabetes mellitus is limited... - Assessment of high-sensitivity C-reactive protein levels as diagnostic discriminator of maturity-onset diabetes of the young due to HNF1A mutationsKatharine R Owen
Oxford Centre for Diabetes Endocrinology and Metabolism, University of Oxford, Oxford, U K
Diabetes Care 33:1919-24. 2010..We hypothesized that serum levels of high-sensitivity C-reactive protein (hs-CRP) could represent a clinically useful biomarker for the identification of HNF1A mutations causing maturity-onset diabetes of the young (MODY)... - Addition of biphasic, prandial, or basal insulin to oral therapy in type 2 diabetesRury R Holman
Diabetes Trials Unit, Oxford Centre for Diabetes, Endocrinology, and Metabolism, Churchill Hospital, University of Oxford, Headington, Oxford, United Kingdom
N Engl J Med 357:1716-30. 2007..Adding insulin to oral therapy in type 2 diabetes mellitus is customary when glycemic control is suboptimal, though evidence supporting specific insulin regimens is limited... - The impact of renin-angiotensin-aldosterone system inhibitors on Type 1 and Type 2 diabetic patients with and without early diabetic nephropathyJennifer A Hirst
Department of Primary Care Health Sciences, University of Oxford, Oxford, UK
Kidney Int 81:674-83. 2012..Treatment reduced urinary albumin excretion for Type 2 diabetic patients with and without microalbuminuria... - Potential impact of omega-3 treatment on cardiovascular disease in type 2 diabetesJanine Hartweg
Division of Public Health and Primary Healthcare, University of Oxford, Oxford, UK
Curr Opin Lipidol 20:30-8. 2009.... - Evaluation of serum 1,5 anhydroglucitol levels as a clinical test to differentiate subtypes of diabetesAparna Pal
Diabetes Research Laboratories, Oxford Centre for Diabetes, Endocrinology and Metabolism, University of Oxford, Oxford, UK
Diabetes Care 33:252-7. 2010..We evaluated serum 1,5AG in a range of diabetes subtypes as an adjunct for defining diabetes etiology... - Change in stroke incidence, mortality, case-fatality, severity, and risk factors in Oxfordshire, UK from 1981 to 2004 (Oxford Vascular Study)P M Rothwell
Stroke Prevention Research Unit, Department of Clinical Neurology, University of Oxford, Oxford, UK
Lancet 363:1925-33. 2004..We aimed to obtain these data... - Atorvastatin in Factorial with Omega-3 EE90 Risk Reduction in Diabetes (AFORRD): a randomised controlled trialR R Holman
Diabetes Trials Unit, Oxford Centre for Diabetes, Endocrinology and Metabolism, Churchill Hospital, Headington, Oxford, UK
Diabetologia 52:50-9. 2009.... - Quantifying the effect of metformin treatment and dose on glycemic controlJennifer A Hirst
Department of Primary Care Health Sciences, University of Oxford, Oxford, UK
Diabetes Care 35:446-54. 2012..We reviewed the literature to quantify the effect of metformin treatment on glycated hemoglobin (HbA(1c)) levels in all types of diabetes and examine the impact of differing doses on glycemic control... - Meta-analysis of individual patient data in randomised trials of self monitoring of blood glucose in people with non-insulin treated type 2 diabetesAndrew J Farmer
Department of Primary Health Care, University of Oxford, and NIHR School for Primary Care Research, Oxford OX1 2ET, UK
BMJ 344:e486. 2012..To assess the effectiveness of self monitoring blood glucose levels in people with non-insulin treated type 2 diabetes compared with clinical management without self monitoring, and to explore the effects in specific patient groups... - A systematic review assessing the effectiveness of interventions to improve persistence with anti-resorptive therapy in women at high risk of clinical fractureH J White
University of Oxford Clinical School, John Radcliffe Hospital, Oxford, UK
Fam Pract 27:593-603. 2010..despite availability of effective treatments for osteoporosis, impact on fracture rates may be suboptimal because of failure to adhere to recommended anti-resorptive therapy... - A1C to detect diabetes in healthy adults: when should we recheck?Osamu Takahashi
Department of Primary Health Care, University of Oxford, Oxford, U K
Diabetes Care 33:2016-7. 2010..To evaluate the optimal interval for rechecking A1C levels below the diagnostic threshold of 6.5% for healthy adults... - Using interactive videos in general practice to inform patients about treatment choices: a pilot studyS Shepperd
Department of Public Health and Primary Care, University of Oxford, UK
Fam Pract 12:443-7. 1995.... - On real-time estimates of blood glucose levels: response to TreviñoOliver J Gibson
Diabetes Care 30:e133; author reply e134. 2007